Milton Packer
Founding Member and Former President of · Stony Brook Medicine
Credentials: · ·
History
- Present
Cardiovascular Disease
Internal Medicine
Research
Angiotensin-neprilysin inhibition versus enalapril in heart failure
New England Journal of Medicine · 2014 · 5,269 citations
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
New England Journal of Medicine · 2020 · First of 40 authors · 3,977 citations
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
New England Journal of Medicine · 2021 · 3,859 citations
- SS
178 papers
161 papers
132 papers
- AD
112 papers
73 papers · 11 as a fellow
- MP
47 papers
36 papers
- IA
33 papers
Grants
- 2007–2012
North and Central Texas Clinical and Translational Science Initiative (UL1)
National Center for Research Resources · UL1
Contact PI · $21.9M · Ut Southwestern Medical Center
- 2007–2012
North and Central Texas Clinical and Translational Science Initiative (KL2)
National Center for Research Resources · KL2
Contact PI · $3.4M · Ut Southwestern Medical Center
- 2007–2012
North and Central Texas Clinical and Translational Science Initiative (TL1)
National Center for Research Resources · TL1
Contact PI · $151.9K · Ut Southwestern Medical Center
- 2005–2010
Southwestern Clinical Science Scholars Program (RMI)
National Center for Research Resources · K12
Contact PI · $3.5M · Ut Southwestern Medical Center
Clinical trials
- 2007–2012
PREVENT-HF: Prevention of Heart Failure Events With Impedance Cardiography Testing
Principal investigator · Unknown · Phase 4
CardioDynamics
- 2012–2016
Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure
Study chair · Completed · Phase 3
Cardiorentis
- 2004–2006
Study of DITPA in Patients With Congestive Heart Failure
Study chair · Terminated · Phase 2
Titan Pharmaceuticals